Daniel Robert Neill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Robert Neill has a total of 332 co-authors. Here are the top co-authors by number of shared publications:
- Aras Kadioglu
Department of Clinical Infection, Microbiology and Immunology, University of Liverpool
22 shared publications - Joanne L. Fothergill
Department of Clinical Infection, Microbiology and Immunology, University of Liverpool
9 shared publications - Angharad E. Green
Advanced Research Computing Centre (ARC), University College London, London WC1E 6EA, UK
8 shared publications Thomas E. Barton
Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
5 shared publications- Craig Winstanley
Institute of Infection and Global Health, University of Liverpool, Liverpool, UK
4 shared publications Laura Bricio-Moreno
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Metabolization of human milk oligosaccharides by Streptococcus pneumoniae
It is unclear whether human milk oligosaccharides (HMOs) can be used as a nutrient source by Streptococcus pneumoniae . Here, we investigate whether and how S. pneumoniae metabolizes HMOs and whether these compounds inhibit pneumococcal adherence. We find that S. pneumoniae can metabolize several HMOs, except for 2’-fucosyllactose (2’FL). The process is regulated by the carbon catabolite repression system. Transcriptome analyses showed reduced expression of the lac operon I ( lacABCD ) in bacteria grown with two tested HMOs when compared to lactose (Lac). Genes for the Leloir pathway and exoglycosidases were upregulated. A genome-wide CRISPR interference screen showed that the lac operons I and II ( lacEFG-2 ) are essential for metabolizing HMOs. Lac and non-metabolizable 2’FL were found to inhibit pneumococcal adherence to host cells in vitro. Importantly, 2’FL showed a stronger inhibitory effect compared to Lac in vivo. Further research is warranted to investigate whether the non-metabolizable 2’FL can be used to inhibit pneumococcal adherence.
- 30 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMetabolization of human milk oligosaccharides by Streptococcus pneumoniae
It is unclear whether human milk oligosaccharides (HMOs) can be used as a nutrient source by Streptococcus pneumoniae . Here, we investigate whether and how S. pneumoniae metabolizes HMOs and whether these compounds inhibit pneumococcal adherence. We find that S. pneumoniae can metabolize several HMOs, except for 2’-fucosyllactose (2’FL). The process is regulated by the carbon catabolite repression system. Transcriptome analyses showed reduced expression of the lac operon I ( lacABCD ) in bacteria grown with two tested HMOs when compared to lactose (Lac). Genes for the Leloir pathway and exoglycosidases were upregulated. A genome-wide CRISPR interference screen showed that the lac operons I and II ( lacEFG-2 ) are essential for metabolizing HMOs. Lac and non-metabolizable 2’FL were found to inhibit pneumococcal adherence to host cells in vitro. Importantly, 2’FL showed a stronger inhibitory effect compared to Lac in vivo. Further research is warranted to investigate whether the non-metabolizable 2’FL can be used to inhibit pneumococcal adherence.
- Open Access
Niche-specific contribution of the branched-chain amino acid biosynthesis protein IlvD in Streptococcus pneumoniae infection
Systemic pneumococcal infections are a major cause of morbidity and mortality. Pneumococci isolated from bacteraemia lack clear genetic signatures distinguishing them from isolates recovered from other disease sites. The bloodstream is an evolutionary dead end, providing no means of onward transmission, and acute bacteraemic events offer limited opportunity for within-host evolution. Nonetheless, we reasoned that it might be possible to identify genetic determinants of virulence in blood through genomic comparison of matched lung and blood isolates from individual infections. Using samples from a mouse invasive pneumonia model, we observed frequent occurrence of low population frequency mutations in ilvD - encoding a branched-chain amino acid (BCAA) biosynthesis protein - in bloodstream isolates. These mutations were absent from the lung-resident bacterial population. The single-nucleotide polymorphisms in ilvD clustered in a short stretch of nucleotides that are highly conserved across bacteria, suggesting they might disrupt protein function. Deletion of ilvD or introduction of identified SNPs in pneumococcal strain D39 conferred competitive advantages in both in vitro environments mimicking the bloodstream and in mouse bacteraemia models. Improved survival of ilvD mutants within phagocytic cells was dependent on iron availability. Conversely, disruption of ilvD reduced fitness in the nasopharynx, suggesting BCAA biosynthesis is required for upper airway colonisation but is a liability in the context of systemic infection. Nasopharyngeal colonisation defects could be rescued by administering intranasal BCAA to infected mice, suggesting loss of capacity for de novo BCAA synthesis in ilvD mutants accounted for reduced upper airway fitness. In support of a critical role for BCAA biosynthesis in the primary commensal lifestyle of pneumococcus, genomic analysis of clinical isolates demonstrated that ilvD is under purifying selection. Collectively, these findings highlight the context-specific role of IlvD and BCAA biosynthesis in infection, with a requirement for protein function in the BCAA-restricted environment of nasopharynx, but fitness benefits deriving from loss of IlvD and its associated iron-sulfur cluster, in the BCAA-rich conditions of blood.
Open AccessNiche-specific contribution of the branched-chain amino acid biosynthesis protein IlvD in Streptococcus pneumoniae infection
Systemic pneumococcal infections are a major cause of morbidity and mortality. Pneumococci isolated from bacteraemia lack clear genetic signatures distinguishing them from isolates recovered from other disease sites. The bloodstream is an evolutionary dead end, providing no means of onward transmission, and acute bacteraemic events offer limited opportunity for within-host evolution. Nonetheless, we reasoned that it might be possible to identify genetic determinants of virulence in blood through genomic comparison of matched lung and blood isolates from individual infections. Using samples from a mouse invasive pneumonia model, we observed frequent occurrence of low population frequency mutations in ilvD - encoding a branched-chain amino acid (BCAA) biosynthesis protein - in bloodstream isolates. These mutations were absent from the lung-resident bacterial population. The single-nucleotide polymorphisms in ilvD clustered in a short stretch of nucleotides that are highly conserved across bacteria, suggesting they might disrupt protein function. Deletion of ilvD or introduction of identified SNPs in pneumococcal strain D39 conferred competitive advantages in both in vitro environments mimicking the bloodstream and in mouse bacteraemia models. Improved survival of ilvD mutants within phagocytic cells was dependent on iron availability. Conversely, disruption of ilvD reduced fitness in the nasopharynx, suggesting BCAA biosynthesis is required for upper airway colonisation but is a liability in the context of systemic infection. Nasopharyngeal colonisation defects could be rescued by administering intranasal BCAA to infected mice, suggesting loss of capacity for de novo BCAA synthesis in ilvD mutants accounted for reduced upper airway fitness. In support of a critical role for BCAA biosynthesis in the primary commensal lifestyle of pneumococcus, genomic analysis of clinical isolates demonstrated that ilvD is under purifying selection. Collectively, these findings highlight the context-specific role of IlvD and BCAA biosynthesis in infection, with a requirement for protein function in the BCAA-restricted environment of nasopharynx, but fitness benefits deriving from loss of IlvD and its associated iron-sulfur cluster, in the BCAA-rich conditions of blood.
- Open Access
- 12 January 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (1) , 001627
The longitudinal expression of P. aeruginosa reference genes in infection-mimicking media
Quantitative reverse transcription PCR (RT-qPCR) is a popular and reliable tool for monitoring fluctuations in functional bacterial gene expression. A necessary step of the qRT-qPCR process is the use of a reference gene, which acts to distinguish between technical bias and true biological variation. Many reference genes have been defined for bacterial species; however, few studies have validated their stability across strain types and environmental test conditions. In this study of Pseudomonas aeruginosa , the expression consistency of seven commonly used reference genes ( rpoD , proC , rpoS , 16S , algD , gyrA and ampC ) was assessed in P. aeruginosa laboratory (PAO1) and clinical (LESB65) isolates grown in Lysogeny broth, synthetic cystic fibrosis (CF) media 2 (SCFM2) and CF lung media (CFLM) at various growth time points (2, 6, 24 and 72 h). The stability of the reference genes was then ranked using the RefFinder programme, and three differentially ranked ( rpoS , 16S and ampC ) were used to interpret the expression of a Pseudomonas virulence-related gene ( exoS ). The results showed that 16S was the only reference gene that was quantifiably expressed by both P. aeruginosa strains grown in all media types at all growth times. Furthermore, analysing the expression of exoS with different reference genes significantly influenced the calculated expression of exoS in SCFM2 and CFLM. This study has identified a suitable reference gene for RT-qPCR with P. aeruginosa grown in complex respiratory-mimicking media. The results presented here also highlight the importance of validating reference gene expression under the chosen experimental conditions and increase our understanding of how pathogen biology can fluctuate across diverse conditions. Such knowledge is paramount for the development of novel therapeutics, including antimicrobials and anti-virulence agents.
- 12 January 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (1) , 001627
Open AccessThe longitudinal expression of P. aeruginosa reference genes in infection-mimicking media
Quantitative reverse transcription PCR (RT-qPCR) is a popular and reliable tool for monitoring fluctuations in functional bacterial gene expression. A necessary step of the qRT-qPCR process is the use of a reference gene, which acts to distinguish between technical bias and true biological variation. Many reference genes have been defined for bacterial species; however, few studies have validated their stability across strain types and environmental test conditions. In this study of Pseudomonas aeruginosa , the expression consistency of seven commonly used reference genes ( rpoD , proC , rpoS , 16S , algD , gyrA and ampC ) was assessed in P. aeruginosa laboratory (PAO1) and clinical (LESB65) isolates grown in Lysogeny broth, synthetic cystic fibrosis (CF) media 2 (SCFM2) and CF lung media (CFLM) at various growth time points (2, 6, 24 and 72 h). The stability of the reference genes was then ranked using the RefFinder programme, and three differentially ranked ( rpoS , 16S and ampC ) were used to interpret the expression of a Pseudomonas virulence-related gene ( exoS ). The results showed that 16S was the only reference gene that was quantifiably expressed by both P. aeruginosa strains grown in all media types at all growth times. Furthermore, analysing the expression of exoS with different reference genes significantly influenced the calculated expression of exoS in SCFM2 and CFLM. This study has identified a suitable reference gene for RT-qPCR with P. aeruginosa grown in complex respiratory-mimicking media. The results presented here also highlight the importance of validating reference gene expression under the chosen experimental conditions and increase our understanding of how pathogen biology can fluctuate across diverse conditions. Such knowledge is paramount for the development of novel therapeutics, including antimicrobials and anti-virulence agents.
- Open Access
- 20 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A poly(trisulfide) prodrug with antimicrobial activity
Antimicrobial resistance is a growing threat to human health and agriculture. Sulfur-containing compounds and elemental sulfur have a long history of use as antimicrobials, but challenges related to solubility and formulation have limited their broad application. Recent advances in sulfur polymer chemistry have enabled the development of novel sulfur-rich materials with antimicrobial activity. However, most of these materials are water-insoluble, limiting their use in biomedical and agricultural applications. Here, we report the synthesis of a linear poly(trisulfide) via photochemical ring-opening polymerization of a cyclic trisulfide monomer bearing a carboxylic acid. Deprotonation of the carboxylic acid renders the poly(trisulfide) fully water soluble, with concomitant chain scission via S-S cleavage. The resulting poly(trisulfide) oligomers exhibited potent antifungal activity against Candida albicans (MIC < 8 µg/mL), and stronger inhibition of the Gram-positive bacterium Staphylococcus aureus (MIC = 16 µg/mL) compared to the Gram-negative Escherichia coli (MIC > 512 µg/mL). In control experiments, the monomer did not show potent antifungal or antibacterial activity. This work demonstrates a simple and controllable synthesis of a poly(trisulfide) species that serves as a prodrug: treatment with NaOH converts the polymer to water-soluble oligomers with antimicrobial activity. This approach is a new direction for biological applications of sulfur polymers and a new strategy to address antimicrobial resistance.
- 20 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA poly(trisulfide) prodrug with antimicrobial activity
Antimicrobial resistance is a growing threat to human health and agriculture. Sulfur-containing compounds and elemental sulfur have a long history of use as antimicrobials, but challenges related to solubility and formulation have limited their broad application. Recent advances in sulfur polymer chemistry have enabled the development of novel sulfur-rich materials with antimicrobial activity. However, most of these materials are water-insoluble, limiting their use in biomedical and agricultural applications. Here, we report the synthesis of a linear poly(trisulfide) via photochemical ring-opening polymerization of a cyclic trisulfide monomer bearing a carboxylic acid. Deprotonation of the carboxylic acid renders the poly(trisulfide) fully water soluble, with concomitant chain scission via S-S cleavage. The resulting poly(trisulfide) oligomers exhibited potent antifungal activity against Candida albicans (MIC < 8 µg/mL), and stronger inhibition of the Gram-positive bacterium Staphylococcus aureus (MIC = 16 µg/mL) compared to the Gram-negative Escherichia coli (MIC > 512 µg/mL). In control experiments, the monomer did not show potent antifungal or antibacterial activity. This work demonstrates a simple and controllable synthesis of a poly(trisulfide) species that serves as a prodrug: treatment with NaOH converts the polymer to water-soluble oligomers with antimicrobial activity. This approach is a new direction for biological applications of sulfur polymers and a new strategy to address antimicrobial resistance.
- Open Access
- 13 November 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (11) , e1013675
The metabolic, microbial and immunological demands of pneumococcal colonisation
Streptococcus pneumoniae (the pneumococcus) causes a range of life-threatening diseases including pneumonia, sepsis and meningitis. Despite widespread vaccine deployment, pneumococcal disease remains a leading cause of global mortality. The human nasopharynx is its principal ecological niche, and all pneumococcal disease originates from this reservoir of organisms. Acute infections are, however, an evolutionary dead-end for the pneumococcus. What sustains the pneumococcus within human populations are cycles of colonisation and transmission. To persist within the nasopharynx, it must overcome the physical and immunological barriers established by the host while acquiring sufficient nutrients to proliferate in the face of competing airway microbes. Here, we outline the metabolic, microbial, and immunological challenges of colonisation, and the often-competing demands of transmission, which together have shaped the pneumococcus into one of the most formidable human pathogens.
- 13 November 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (11) , e1013675
Open AccessThe metabolic, microbial and immunological demands of pneumococcal colonisation
Streptococcus pneumoniae (the pneumococcus) causes a range of life-threatening diseases including pneumonia, sepsis and meningitis. Despite widespread vaccine deployment, pneumococcal disease remains a leading cause of global mortality. The human nasopharynx is its principal ecological niche, and all pneumococcal disease originates from this reservoir of organisms. Acute infections are, however, an evolutionary dead-end for the pneumococcus. What sustains the pneumococcus within human populations are cycles of colonisation and transmission. To persist within the nasopharynx, it must overcome the physical and immunological barriers established by the host while acquiring sufficient nutrients to proliferate in the face of competing airway microbes. Here, we outline the metabolic, microbial, and immunological challenges of colonisation, and the often-competing demands of transmission, which together have shaped the pneumococcus into one of the most formidable human pathogens.
- Open Access
- 8 October 2025
- Published by Microbiology Society in Microbiology
- Vol. 171 (10) , 001617
The influence of Pseudomonas aeruginosa infection on the airway metabolome
Pseudomonas aeruginosa is an environmentally resilient bacterium and an important cause of both acute and chronic infections in people with impaired natural barriers or immunological defences. Chronic respiratory infection with P. aeruginosa is a major cause of morbidity and mortality in people with airway diseases, including cystic fibrosis (CF) and non-CF bronchiectasis. Chronic airway infection is characterized by periods of relative stability punctuated by pulmonary exacerbations, during which times rapid bacterial outgrowth necessitates intense antimicrobial chemotherapy. The periods of stable infection can be modelled in mice by nasal instillation of airway-adapted P. aeruginosa in saline, leading to prolonged colonization of both upper airway (sinus) and lower airway (lung) environments that is not associated with symptomatic disease. Here, we use NMR metabolomics to investigate the impact of P. aeruginosa colonization on the metabolic landscape of sinuses and lungs. Lung infection led to pronounced changes in the airway metabolome, with significant depletion of glucose and myo-inositol but enrichment of glutathione (GSH), relative to uninfected lungs. Changes in the sinuses were more subtle but could be identified through dimensionality reduction approaches. The NMR spectral peaks that discriminated between infected and uninfected sinuses in partial least squares discriminant analysis included those for lactate and choline but were mostly representative of yet unidentified metabolites. These data highlight the differential impact of infection on separate airway compartments and identify undefined metabolites undergoing pronounced abundance changes during infection.
- 8 October 2025
- Published by Microbiology Society in Microbiology
- Vol. 171 (10) , 001617
Open AccessThe influence of Pseudomonas aeruginosa infection on the airway metabolome
Pseudomonas aeruginosa is an environmentally resilient bacterium and an important cause of both acute and chronic infections in people with impaired natural barriers or immunological defences. Chronic respiratory infection with P. aeruginosa is a major cause of morbidity and mortality in people with airway diseases, including cystic fibrosis (CF) and non-CF bronchiectasis. Chronic airway infection is characterized by periods of relative stability punctuated by pulmonary exacerbations, during which times rapid bacterial outgrowth necessitates intense antimicrobial chemotherapy. The periods of stable infection can be modelled in mice by nasal instillation of airway-adapted P. aeruginosa in saline, leading to prolonged colonization of both upper airway (sinus) and lower airway (lung) environments that is not associated with symptomatic disease. Here, we use NMR metabolomics to investigate the impact of P. aeruginosa colonization on the metabolic landscape of sinuses and lungs. Lung infection led to pronounced changes in the airway metabolome, with significant depletion of glucose and myo-inositol but enrichment of glutathione (GSH), relative to uninfected lungs. Changes in the sinuses were more subtle but could be identified through dimensionality reduction approaches. The NMR spectral peaks that discriminated between infected and uninfected sinuses in partial least squares discriminant analysis included those for lactate and choline but were mostly representative of yet unidentified metabolites. These data highlight the differential impact of infection on separate airway compartments and identify undefined metabolites undergoing pronounced abundance changes during infection.
- Open Access
- 2 September 2025
- Published by Elsevier in Cell Host & Microbe
- Vol. 33 (9) , 1473-1483.e6
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes
- 2 September 2025
- Published by Elsevier in Cell Host & Microbe
- Vol. 33 (9) , 1473-1483.e6
Open AccessNaturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes
- 12 October 2024
- Published by MyJove Corporation
- No. 212,p. e67210
JoVE Video Dataset
To combat the rising global issue of antibiotic resistance, the accelerated development of novel antibiotics is essential. Current preclinical antimicrobial development yields a significant number of leads that prove unsuitable either prior to or during clinical trials. To increase the efficiency of preclinical development, relevant, standardized, accessible, and cost-effective models must be developed. Galleria mellonella (greater wax moth) larvae are widely used as an infection model to assess microbial virulence, conduct drug toxicity testing, and serve as a preliminary means of evaluating the in vivo efficacy of novel antimicrobial compounds. These infection models have greater biological relevance than many in vitro screens of comparable throughput and decrease reliance on mammalian models when used as a pre-screen for antimicrobial testing. This protocol describes a standardized methodology for the optimization of G. mellonella infection models, which can be applied to bacterial species and antimicrobial therapeutics of choice. Using the WHO priority pathogen Pseudomonas aeruginosa as an exemplar, we outline steps that can be undertaken to develop a reproducible model of infection and therapeutic testing. This includes recommendations on experimental setup, sample preparation, and infection and treatment protocols. Integration of this model within preclinical antimicrobial development pipelines would decrease reliance on mammalian models, reduce the number of ineffective compounds reaching clinical trials, and ultimately increase the efficiency of preclinical antimicrobial development.
- 12 October 2024
- Published by MyJove Corporation
- No. 212,p. e67210
JoVE Video Dataset
To combat the rising global issue of antibiotic resistance, the accelerated development of novel antibiotics is essential. Current preclinical antimicrobial development yields a significant number of leads that prove unsuitable either prior to or during clinical trials. To increase the efficiency of preclinical development, relevant, standardized, accessible, and cost-effective models must be developed. Galleria mellonella (greater wax moth) larvae are widely used as an infection model to assess microbial virulence, conduct drug toxicity testing, and serve as a preliminary means of evaluating the in vivo efficacy of novel antimicrobial compounds. These infection models have greater biological relevance than many in vitro screens of comparable throughput and decrease reliance on mammalian models when used as a pre-screen for antimicrobial testing. This protocol describes a standardized methodology for the optimization of G. mellonella infection models, which can be applied to bacterial species and antimicrobial therapeutics of choice. Using the WHO priority pathogen Pseudomonas aeruginosa as an exemplar, we outline steps that can be undertaken to develop a reproducible model of infection and therapeutic testing. This includes recommendations on experimental setup, sample preparation, and infection and treatment protocols. Integration of this model within preclinical antimicrobial development pipelines would decrease reliance on mammalian models, reduce the number of ineffective compounds reaching clinical trials, and ultimately increase the efficiency of preclinical antimicrobial development.
- 11 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67210
Galleria mellonella as an Antimicrobial Screening Model
To combat the rising global issue of antibiotic resistance, the accelerated development of novel antibiotics is essential. Current preclinical antimicrobial development yields a significant number of leads that prove unsuitable either prior to or during clinical trials. To increase the efficiency of preclinical development, relevant, standardized, accessible, and cost-effective models must be developed. Galleria mellonella (greater wax moth) larvae are widely used as an infection model to assess microbial virulence, conduct drug toxicity testing, and serve as a preliminary means of evaluating the in vivo efficacy of novel antimicrobial compounds. These infection models have greater biological relevance than many in vitro screens of comparable throughput and decrease reliance on mammalian models when used as a pre-screen for antimicrobial testing. This protocol describes a standardized methodology for the optimization of G. mellonella infection models, which can be applied to bacterial species and antimicrobial therapeutics of choice. Using the WHO priority pathogen Pseudomonas aeruginosa as an exemplar, we outline steps that can be undertaken to develop a reproducible model of infection and therapeutic testing. This includes recommendations on experimental setup, sample preparation, and infection and treatment protocols. Integration of this model within preclinical antimicrobial development pipelines would decrease reliance on mammalian models, reduce the number of ineffective compounds reaching clinical trials, and ultimately increase the efficiency of preclinical antimicrobial development.
- 11 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67210
Galleria mellonella as an Antimicrobial Screening Model
To combat the rising global issue of antibiotic resistance, the accelerated development of novel antibiotics is essential. Current preclinical antimicrobial development yields a significant number of leads that prove unsuitable either prior to or during clinical trials. To increase the efficiency of preclinical development, relevant, standardized, accessible, and cost-effective models must be developed. Galleria mellonella (greater wax moth) larvae are widely used as an infection model to assess microbial virulence, conduct drug toxicity testing, and serve as a preliminary means of evaluating the in vivo efficacy of novel antimicrobial compounds. These infection models have greater biological relevance than many in vitro screens of comparable throughput and decrease reliance on mammalian models when used as a pre-screen for antimicrobial testing. This protocol describes a standardized methodology for the optimization of G. mellonella infection models, which can be applied to bacterial species and antimicrobial therapeutics of choice. Using the WHO priority pathogen Pseudomonas aeruginosa as an exemplar, we outline steps that can be undertaken to develop a reproducible model of infection and therapeutic testing. This includes recommendations on experimental setup, sample preparation, and infection and treatment protocols. Integration of this model within preclinical antimicrobial development pipelines would decrease reliance on mammalian models, reduce the number of ineffective compounds reaching clinical trials, and ultimately increase the efficiency of preclinical antimicrobial development.
- Open Access
- 8 January 2024
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 18 (1)
Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments
Pseudomonas aeruginosa is a cause of chronic respiratory tract infections in people with cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease. Prolonged infection allows the accumulation of mutations and horizontal gene transfer, increasing the likelihood of adaptive phenotypic traits. Adaptation is proposed to arise first in bacterial populations colonizing upper airway environments. Here, we model this process using an experimental evolution approach. Pseudomonas aeruginosa PAO1, which is not airway adapted, was serially passaged, separately, in media chemically reflective of upper or lower airway environments. To explore whether the CF environment selects for unique traits, we separately passaged PAO1 in airway-mimicking media with or without CF-specific factors. Our findings demonstrated that all airway environments—sinus and lungs, under CF and non-CF conditions—selected for loss of twitching motility, increased resistance to multiple antibiotic classes, and a hyper-biofilm phenotype. These traits conferred increased airway colonization potential in an in vivo model. CF-like conditions exerted stronger selective pressures, leading to emergence of more pronounced phenotypes. Loss of twitching was associated with mutations in type IV pili genes. Type IV pili mediate surface attachment, twitching, and induction of cAMP signalling. We additionally identified multiple evolutionary routes to increased biofilm formation involving regulation of cyclic-di-GMP signalling. These included the loss of function mutations in bifA and dipA phosphodiesterase genes and activating mutations in the siaA phosphatase. These data highlight that airway environments select for traits associated with sessile lifestyles and suggest upper airway niches support emergence of phenotypes that promote establishment of lung infection.
- 8 January 2024
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 18 (1)
Open AccessSecondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments
Pseudomonas aeruginosa is a cause of chronic respiratory tract infections in people with cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease. Prolonged infection allows the accumulation of mutations and horizontal gene transfer, increasing the likelihood of adaptive phenotypic traits. Adaptation is proposed to arise first in bacterial populations colonizing upper airway environments. Here, we model this process using an experimental evolution approach. Pseudomonas aeruginosa PAO1, which is not airway adapted, was serially passaged, separately, in media chemically reflective of upper or lower airway environments. To explore whether the CF environment selects for unique traits, we separately passaged PAO1 in airway-mimicking media with or without CF-specific factors. Our findings demonstrated that all airway environments—sinus and lungs, under CF and non-CF conditions—selected for loss of twitching motility, increased resistance to multiple antibiotic classes, and a hyper-biofilm phenotype. These traits conferred increased airway colonization potential in an in vivo model. CF-like conditions exerted stronger selective pressures, leading to emergence of more pronounced phenotypes. Loss of twitching was associated with mutations in type IV pili genes. Type IV pili mediate surface attachment, twitching, and induction of cAMP signalling. We additionally identified multiple evolutionary routes to increased biofilm formation involving regulation of cyclic-di-GMP signalling. These included the loss of function mutations in bifA and dipA phosphodiesterase genes and activating mutations in the siaA phosphatase. These data highlight that airway environments select for traits associated with sessile lifestyles and suggest upper airway niches support emergence of phenotypes that promote establishment of lung infection.